0000899243-22-015762.txt : 20220427
0000899243-22-015762.hdr.sgml : 20220427
20220427160527
ACCESSION NUMBER: 0000899243-22-015762
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220425
FILED AS OF DATE: 20220427
DATE AS OF CHANGE: 20220427
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ambrose Kristen
CENTRAL INDEX KEY: 0001856587
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 22859500
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-25
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001856587
Ambrose Kristen
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Chief Accounting Officer
Common Stock
2022-04-25
4
S
0
60
267.37
D
3763
D
Common Stock
2022-04-25
4
S
0
80
268.46
D
3683
D
Common Stock
2022-04-25
4
S
0
83
269.51
D
3600
D
Common Stock
2022-04-25
4
S
0
104
271.68
D
3496
D
Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1.
Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $267.37 (range $266.86 to $267.85).
Open market sales reported on this line occurred at a weighted average price of $268.46 (range $268.05 to $268.86).
Open market sales reported on this line occurred at a weighted average price of $269.51 (range $269.12 to $269.90).
Open market sales reported on this line occurred at a weighted average price of $271.68 (range $271.25 to $272.23).
/s/ Sabrina Yohai, Attorney-in-Fact
2022-04-27